Skip to main content

and
  1. Article

    Open Access

    JNK signaling provides a novel therapeutic target for Rett syndrome

    Rett syndrome (RTT) is a monogenic X-linked neurodevelopmental disorder characterized by loss-of-function mutations in the MECP2 gene, which lead to structural and functional changes in synapse communication, ...

    Clara Alice Musi, Anna Maria Castaldo, Anna Elisa Valsecchi, Sara Cimini in BMC Biology (2021)

  2. Article

    Open Access

    Fluoxetine increases brain MeCP2 immuno-positive cells in a female Mecp2 heterozygous mouse model of Rett syndrome through endogenous serotonin

    Motor skill deficit is a common and invalidating symptom of Rett syndrome (RTT), a rare disease almost exclusively affecting girls during the first/second year of life. Loss-of-function mutations of the methyl-Cp...

    Claudia Villani, Mirjana Carli, Anna Maria Castaldo in Scientific Reports (2021)